Umbilical Cord Blood Mononuclear Cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Umbilical Cord Blood Mononuclear Cells, covering 2024-07-11 to 2025-03-13. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation [Phase 1]